One of the major concerns in the electric vehicle market has always been about where drivers can recharge. When you’re at home, of course, the cars can be plugged into certain outlets or home charging stations.
When traveling, however, only public charing stations are available—which come with their own setbacks, such as slow charging times, and the inconvenience of having to leave your vehicle to plug it in.
One company, however, might have come up with a solution to the latter problem… and for once it isn’t Tesla!
Volkswagen AG has officially created the first EV charging station that installs the plug for you.
The design is like a robotic arm that unplugs the charging cord from the station and into the car without any human assistance needed.
Tesla had similar ambitions, but their design was a bit different: instead of having a robot arm to move the cord, Tesla’s cord supposedly moved itself. The snake-like flexibility meant the cord could adjust as needed under its down guidance.
Unfortunately, there is a nominal fee for this automatic charger. And this is where Tesla holds an advantage, since Model S owners have access to all of the company’s Superchargers for free.
And while Volkswagen has won the race to this new technology, it’s possible Tesla will increase its focus on research and development, and win the war in the end.
To continue reading…
Until next time,
A true insider in the technology and energy markets, Keith’s research has helped everyday investors capitalize from the rapid adoption of new technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the Managing Editor of Energy & Capital, as well as the investment director of Angel Publishing’s Energy Investor and Technology and Opportunity.
For nearly two decades, Keith has been providing in-depth coverage of the hottest investment trends before they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on key advancements in robotics and AI technology.
Keith’s keen trading acumen and investment research also extend all the way into the complex biotech sector, where he and his readers take advantage of the newest and most groundbreaking medical therapies being developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s to lab scientists grinding out the latest medical technology and treatments. You can join his vast investment community and target the most profitable biotech stocks in Keith’s Topline Trader advisory newsletter.